Lindbrook Capital’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$51 Hold
4
﹤0.01% 2764
2024
Q4
$69 Sell
4
-482
-99% -$9.63K ﹤0.01% 2749
2024
Q3
$11K Buy
486
+482
+12,050% +$11K ﹤0.01% 1628
2024
Q2
$99 Sell
4
-61
-94% -$1.73K ﹤0.01% 2717
2024
Q1
$2.14K Sell
65
-6
-8% -$204 ﹤0.01% 2219
2023
Q4
$2.58K Sell
71
-103
-59% -$3.54K ﹤0.01% 2178
2023
Q3
$6.39K Buy
174
+20
+13% +$797 ﹤0.01% 1654
2023
Q2
$5.9K Buy
154
+12
+8% +$444 ﹤0.01% 1725
2023
Q1
$5.82K Buy
142
+38
+37% +$1.59K ﹤0.01% 1787
2022
Q4
$3.61K Buy
104
+13
+14% +$455 ﹤0.01% 1972
2022
Q3
$3K Sell
91
-72
-44% -$2.34K ﹤0.01% 1826
2022
Q2
$5K Buy
163
+140
+609% +$4.7K ﹤0.01% 1517
2022
Q1
$1K Buy
23
+19
+475% +$816 ﹤0.01% 2146
2021
Q4
$0 Buy
+4
New +$179 ﹤0.01% 2057
2019
Q2
Sell
-2
Closed 1386
2019
Q1
$0 Hold
2
﹤0.01% 1381
2018
Q4
$0 Buy
+2
New +$52 ﹤0.01% 1344

Other funds holding ADNT

Lindbrook Capital's ADNT Position: Q1 2025 in Review

Lindbrook Capital held its Adient (ADNT) position steady in Q1 2025 at 4 shares worth $51. The position accounts for ﹤0.01% of the portfolio, ranked #2764.

Lindbrook Capital first reported a position in ADNT in Q4 2018 and has held it in 16 quarters since. The position peaked at $11K in Q3 2024. 270 funds tracked by Wall St. Rank hold ADNT as of Q1 2025.

  • Lindbrook Capital held 4 shares of Adient worth $51 as of Q1 2025.
  • Lindbrook Capital left its Adient share count unchanged in Q1 2025.
  • Adient made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2764 holding.
  • Lindbrook Capital first reported a position in Adient in Q4 2018 and has held it in 16 quarters since.
  • Lindbrook Capital's Adient position peaked at $11K in Q3 2024.
  • 270 funds tracked by Wall St. Rank held Adient as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.